Matinas BioPharma Holdings (MTNB) Other Non-Current Assets (2017 - 2026)
Matinas BioPharma Holdings (MTNB) reported Other Non-Current Assets of $200,000 for Q1 2026, unchanged from $200,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Dating back to Q4 2017, Matinas BioPharma Holdings' Other Non-Current Assets record includes 34 quarters.
- Other Non-Current Assets has a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- By year, Other Non-Current Assets came in at $200,000 in FY2024 (unchanged), $200,000 in FY2023 (unchanged), $200,000 in FY2022 (unchanged) and $200,000 in FY2021 (unchanged).
- Five-year quarterly Other Non-Current Assets spans a low of $200,000 in Q4 2021 and a high of $300,000 in Q3 2022.
- The year-over-year decline in Other Non-Current Assets has ranged between 0.0% (Q1 2026) and 40.0% (Q2 2021) over the last five years.
- Per Business Quant data, the three quarters before Q1 2026 came in at $200,000 (Q4 2025), $200,000 (Q3 2025) and $200,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Matinas BioPharma Holdings | 16.34 Mn | 3.74 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
API Access
Matinas BioPharma Holdings Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();